1 year return (CAGR)
-33.83%
Erytech Pharma S.A. ADR Exchange (NASDAQ, USD)
ERYP
-
+0.03 (+4.85%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-56.14%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
41.41M
Price/Sales
-
Ent value
24.94M
Price/Book
1.76
Div yield
-
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
67.44
PEG
-
Forward P/E
-
EPS growth
-66.92%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.63 |
| Daily high | 0.70 |
| Daily low | 0.61 |
| Daily Volume | 13K |
| 1y analyst estimate | 2.96 |
| Beta | 2.13 |
| EPS (TTM) | 0.02 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ERYP | S&P500 | |
| Current price drop from All-time high | -97.89% | -4.66% |
| Highest price drop | -98.98% | -56.47% |
| Date of highest drop | 30 Dec 2022 | 9 Mar 2009 |
| Avg drop from high | -79.50% | -10.68% |
| Avg time to new high | 1242 days | 12 days |
| Max time to new high | 1241 days | 1805 days |
News
No items found